¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Asymptomatic human immuno- deficiency virus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • oncogenic virus
    Á¾¾ç¹ß»ý¹ÙÀÌ·¯½º
  • orphan virus
    °í¾Æ¹ÙÀÌ·¯½º
  • parainfluenza virus
    ÆÄ¶óÀÎÇ÷翣ÀÚ¹ÙÀÌ·¯½º
  • passenger virus
    Àϰú¼º¹ÙÀÌ·¯½º, ³ª±×³×¹ÙÀÌ·¯½º
  • respiratory syncytial virus
    È£Èí±â¼¼Æ÷À¶ÇÕ¹ÙÀÌ·¯½º
  • RNA virus
    RNA¹ÙÀÌ·¯½º
  • street virus
    °Å¸®¹ÙÀÌ·¯½º, ¾ß»ý±¤°ßº´¹ÙÀÌ·¯½º
  • simian virus
    ¿ø¼þÀ̹ÙÀÌ·¯½º
  • slow virus
    ½½·Î¿ì¹ÙÀÌ·¯½º
  • virus
    ¹ÙÀÌ·¯½º
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ
  • varicella-zoster virus
    ¼öµÎ´ë»óÆ÷Áø¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • RNA virus
    ¾Ë¿£¿¡À̹ÙÀÌ·¯½º
  • simian virus
    ¿ø¼þÀ̹ÙÀÌ·¯½º
  • street virus
    ¾ß»ý¹ÌÄ£°³º´¹ÙÀÌ·¯½º
  • virus-induced tumor
    ¹ÙÀÌ·¯½ºÀ¯¹ßÁ¾¾ç
  • virus
    ¹ÙÀÌ·¯½º
  • virus-specific
    ¹ÙÀÌ·¯½ºÆ¯ÀÌ-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • glucose 6 phosphatase deficiency hepa
    ±Û·çÄÚ¿À½º-6 -ÀÎ»ê °áÇ̰£½ÅÇü´ç
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-ÀλêµðÇÏÀÌ µå·ÎÀú³×À̽º °áÇÌ(Áõ)
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
  • glutathione reductase deficiency
    ±Û·çŸƼ¿Â ȯ¿øÈ¿¼Ò °áÇÌÁõ.
  • glycosidase deficiency
    ±Û¸®ÄڽôپÆÁ¦°áÇÌ(Áõ).
  • gonadal deficiency
    »ý½Ä¼±ºÎÀü(ßæãÖàÍÝÕîï).
  • gonadal deficiency
    »ý½Ä¼±ºÎÀü(ßæãÖàÍÝÕîï).
  • hepatophosphorylase deficiency
    °£Æ÷½ºÆ÷¸±¶ó¾ÆÁ¦°áÇÌÁõ.
  • hexokinase deficiency
    Çí¼ÒÄ«À̳×À̽º°áÇÌ.
  • hexokinase deficiency
    Çí¼ÒŰ³ªÁ¦°áÇÌ.
  • hexosaminidase a deficiency
    Çí¼Ò»ç¹Ì´Ïµ¥À̽º A °áÇÌ(Áõ)
  • iduronate sulfatase deficiency
    Iduronate sulfatase deficiency
  • iga deficiency
    ¸é¿ª±Û·ÎºÒ¸° A °áÇÌ
  • immune deficiency disease
    ¸é¿ª°áÇÌÁúȯ<º´>.
  • immunoglobulin A deficiency
    ¸é¿ª±Û·ÎºÒ¸° A °áÇÌ(Áõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • human leukocyte antigen(hla) complex,class ii
    2±º
  • human menopausal gonadotropin =hMG
    (»ç¶÷)Æä°æ¿©¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  • human milk
    ¸ðÀ¯(Ù½êá), ÀÎÀ¯(ìÑêá).
  • human oncovirus
    »ç¶÷ ¾Ï¹ÙÀÌ·¯½º
  • human papillomavirus
    ÀÎüÀ¯µÎÁ¾¹ÙÀÌ·¯½º
  • human papillomavirus
    ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º
  • human papillomavirus
    ÀÎ À¯µÎÁ¾ ¹ÙÀÌ·¯½º
  • human parvovirus-like agent
    »ç¶÷ ÆÄº¸¹ÙÀÌ·¯½º À¯»çü
  • human pituitary follicle stimulating hormone =HPFSH
    »ç¶÷³úÇϼöü³­Æ÷ÀÚ±ØÈ£¸£¸ó.
  • human pituitary follicle stimulating hormone =HPFSH
    ³úÇϼöü³­Æ÷ÀÚ±ØÈ£¸£¸ó.
  • human pituitary follicle stimulating hormone =hPFSH
    ³úÇϼöü³­Æ÷ÀÚ±ØÈ£¸£¸ó.
  • human pituitary gonadotropin =HPG
    »ç¶÷³úÇϼöü¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • human pituitary gonadotropin =HPG
    ³úÇϼöü¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • human pituitary gonadotropin =hPG
    ³úÇϼöü¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • human placenta
    »ç¶÷ŹÝ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
IHGD isolateral human growth deficiency
VAD venous access device; ventricular assist device; vinblastine and dexamethasone; vitamin A deficiency...
CIE Counter(current) Immuno-Electrophoresis; ¿ª¸é¿ª Àü±â ¿µµ¿¹ý
EIA   1) Exercise Induced Asthma; ¿îµ¿ À¯¹ß¼º õ½Ä
  = EIB
  2) Enzyme Immu...
ELISA Enzyme-Linked Immuno-Sorbent Assay; È¿¼Ò ¸é¿ª¹ý
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
IHC Immuno-histochemistry
IPTH Immuno-reactive parathormone
ITIM Immuno-receptor Tyrosine-based Inhibitory Motif
IEMA immuno-enzymometric assays
MIF Micro-immuno-fluorescence
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vitamin B2 deficiency
    ºñŸ¹Î B2 °áÇÌÁõ
  • vitamin D deficiency
    ºñŸ¹Î D °áÇÌ, ºñŸ¹Î D °áÇÌÁõ
    ±¸·çº´-°ñ¿¬È­ÁõÀ¸·Î µî»À³ª °¡½¿»À µûÀ§°¡ ±Á´Â º´. °ö»çº´.
  • vitamin deficiency
    ºñŸ¹Î °áÇÌ, ºñŸ¹Î °áÇÌÁõ
    ¸é Á¾·ùÀÇ ½ÄǰÀ» ¼¯Àº º¸ÅëÀÇ ½Ä»ç¸¦ º¸Åë Á¶¸®¹ý¿¡ µû¶ó ¸ÔÀ» °æ¿ì´Â ºñŸ¹Î °áÇÌÁõÀÌ ³ªÅ¸³ªÁö ¾Ê´Â´Ù. ±×·¯³ª ¿¹¿Ü·Î½á ºñŸ¹Î D°áÇÌÁõÀº ÀÚÁÖ ³ªÅ¸³­´Ù. ½Äǰ Áß¿¡´Â ¿©·¯ Á¾·ùÀÇ ºñŸ¹ÎÀÌ °øÁ¸Çϰí Àֱ⠶§¹®¿¡ 1 Á¾·ù¸¸ÀÇ ºñŸ¹Î °áÇÌÁõº¸´Ùµµ ¿©·¯ Á¾·ùÀÇ ºñŸ¹Î °áÇÌÁõÀÌ ¸¹´Ù. ¼ÒÈ­±â Áúȯ¿¡ ¼ö¹ÝµÇ´Â Èí¼öÀå¾Ö, °¢Á¾ ¾àÀçÀÇ º¹¿ë¿¡ ÀÇÇÑ Àå³» ¼¼±ÕÃþÀÇ º¯È­, ü³»¿¡¼­ÀÇ ºñŸ¹Î Ȱ¼ºÈ­ÀÇ ÀúÇØ, »ý¸®Àû º¯È­¿¡ ´ëÀÀÇÑ ¿ä±¸·®ÀÇ Áõ°¡, °¨¿° µî¿¡ ÀÇÇØ °áÇÌÁõÀÌ ¹ß°ßµÇ´Â °æ¿ì°¡ ÀÖ´Ù. ±×·¯³ª ¾àÇÑ Á¤µµÀÇ °áÇÌÀÎ °æ¿ì¿¡´Â ÀüÇüÀû Áõ»óÀº º¸ÀÌÁö ¾ÊÀ¸¸ç, ÀÌ ¶§ÀÇ Áõ»óÀ» ºñŸ¹Î °¨¼ÒÁõÀ̶ó°í ÇÑ´Ù.
  • vitamin deficiency symptom
    ºñŸ¹Î °áÇÌÁõ
    ºñŸ¹ÎÀÇ ºÎÁ·À¸·Î ÀϾ´Â »ý¸® ±â´É Àå¾Ö. ¾ß¸ÍÁõ, °¢±âº´ µûÀ§°¡ ÀÖ´Ù.
  • vitamin I deficiency
    ºñŸ¹Î °áÇÌ, ºñŸ¹Î °áÇÌÁõ
  • vitamin K deficiency
    ºñŸ¹Î K °áÇÌ, ºñŸ¹Î K °áÇÌÁõ
    Ç÷¾×ÀÇ ÀÀ°í ½Ã°£ÀÌ ±æ¾îÁø´Ù.
  • adeno-associated virus
    ¾Æµ¥³ë °ü·Ã ¹ÙÀÌ·¯½º
  • adventitious virus
    ¿ì¹ß¼º ¹ÙÀÌ·¯½º
  • animal virus
    µ¿¹° ¹ÙÀÌ·¯½º
  • attenuated virus
    µ¶¼º ¾àÈ­ ¹ÙÀÌ·¯½º, º¯¼º ¾àµ¶ ¹ÙÀÌ·¯½º
    ¿¬¼ÓÀû µ¿¹°°è´ë ¶Ç´Â ±âŸ ¹æ¹ý¿¡ ÀÇÇØ º´¿ø¼ºÀ» °¨¼Ò½ÃŲ ¹ÙÀÌ·¯½º.
  • avian infectious bronchitis virus
    Á¶·ù °¨¿°¼º ±â°üÁö¿° ¹ÙÀÌ·¯½º
  • avian influenza virus
    Á¶·ù ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º
  • avian leukosis complex virus
    Á¶·ù ¹éÇ÷±¸Áõ ¹ÙÀÌ·¯½º
  • avian myeloblastosis virus
    Á¶·ù °ñ¼ö¾Æ¼¼Æ÷Áõ ¹ÙÀÌ·¯½º
  • bacterial virus
    ¼¼±Õ ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¿ÀÆÄÁö
    ¼¼±Õ¼º ¹ÙÀÌ·¯½º.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
choline deficiency A condition produced by a deficiency of choline in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline (included in the b vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions.
(12 Dec 1998)
chorionic gonadotropin, beta subunit, human The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (scan j clin lab invest suppl 1993;216:97-104)
(12 Dec 1998)
chorionic gonadotropin, human A human hormone made by chorionic cells (in the foetal part of the placenta), hCG is directed at the gonads and stimulates them. HCG becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hCG in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of Down syndrome and other foetal disorders.
(12 Dec 1998)
chromosomes, human The structures within the human cell nucleus that contain the hereditary material, DNA. There are 46 chromosomes normally present in the human, including two which determine the sex of individual, xx for the female and xy for the male. Human chromosomes are classified into groups sharing structural similarity in terms of length from the centromere.
(12 Dec 1998)
chromosomes, human, 1-3 One of the seven groups of chromosomes containing three pairs conventionally named pairs 1, 2, and 3. The chromosomes in this group, also called group a, are large chromosomes with centromeres approximately in the middle.
(12 Dec 1998)
chromosomes, human, 13-15 The fourth of the seven groups of chromosomes containing three pairs conventionally named pairs 13, 14, and 15. The chromosomes in this group, also called group d, are medium sized with centromeres in the acrocentric position.
(12 Dec 1998)
chromosomes, human, 16-18 The fifth of the seven groups of chromosomes containing three pairs conventionally named pairs 16, 17, and 18. The chromosomes in this group, also called group e, are rather short and submetacentric.
(12 Dec 1998)
chromosomes, human, 19-20 The sixth of the seven groups of chromosomes containing two pairs conventionally named pairs 19 and 20. The chromosomes in this group, also called group f, are short and metacentric.
(12 Dec 1998)
chromosomes, human, 21-22 The seventh of the seven groups of chromosomes containing two pairs conventionally named pairs 21 and 22, and the y chromosome. The chromosomes in this group, also called the g group, are very short and acrocentric.
(12 Dec 1998)
chromosomes, human, 4-5 The second of the seven groups of chromosomes containing two pairs conventionally named pairs 4 and 5. The chromosomes in this group, also called group b, are large with centromeres in the submetacentric position.
(12 Dec 1998)
chromosomes, human, 6-12 The third of the seven groups of chromosomes containing seven pairs conventionally named pairs 6, 7, 8, 9, 10, 11, and 12, and the x chromosome. The chromosomes in this group, also called group c, are medium sized with centromeres in the submetacentric position. The x chromosome most resembles 6. This group presents the major difficulty in the identification of individual chromosomes.
(12 Dec 1998)
chromosomes, human, pair 1 One of the three pairs in the first group (or group a) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 10 One of the seven pairs in the third group (or group c) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 11 One of the seven pairs in the third group (or group c) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 12 One of the seven pairs in the third group (or group c) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á